A detailed history of Td Asset Management Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 109,274 shares of SAGE stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
109,274
Previous 53,662 103.63%
Holding current value
$1.16 Million
Previous $1.16 Million 76.16%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$18.62 - $26.95 $1.04 Million - $1.5 Million
55,612 Added 103.63%
109,274 $2.05 Million
Q4 2023

Feb 12, 2024

SELL
$17.1 - $22.26 $461,700 - $601,020
-27,000 Reduced 33.47%
53,662 $1.16 Million
Q3 2023

Oct 27, 2023

BUY
$16.75 - $48.98 $1.15 Million - $3.36 Million
68,588 Added 568.06%
80,662 $1.66 Million
Q2 2023

Aug 09, 2023

SELL
$40.65 - $59.54 $1.48 Million - $2.17 Million
-36,381 Reduced 75.08%
12,074 $567,000
Q4 2022

Feb 06, 2023

SELL
$32.2 - $43.61 $350,980 - $475,349
-10,900 Reduced 18.36%
48,455 $1.85 Million
Q3 2022

Nov 07, 2022

BUY
$32.28 - $43.27 $12,912 - $17,308
400 Added 0.68%
59,355 $2.35 Million
Q2 2022

Aug 04, 2022

SELL
$27.52 - $37.99 $149,846 - $206,855
-5,445 Reduced 8.45%
58,955 $1.9 Million
Q1 2022

May 10, 2022

BUY
$30.71 - $45.71 $632,626 - $941,626
20,600 Added 47.03%
64,400 $2.13 Million
Q2 2021

Aug 11, 2021

SELL
$54.88 - $79.29 $927,472 - $1.34 Million
-16,900 Reduced 27.84%
43,800 $1.92 Million
Q1 2021

May 14, 2021

BUY
$70.65 - $96.76 $374,868 - $513,408
5,306 Added 9.58%
60,700 $4.54 Million
Q4 2020

Feb 16, 2021

SELL
$58.41 - $89.06 $309,573 - $472,018
-5,300 Reduced 8.73%
55,394 $4.79 Million
Q2 2020

Aug 13, 2020

BUY
$25.95 - $43.15 $486,510 - $808,976
18,748 Added 44.7%
60,694 $2.52 Million
Q1 2020

May 15, 2020

SELL
$26.15 - $77.24 $1.68 Million - $4.96 Million
-64,267 Reduced 60.51%
41,946 $1.21 Million
Q4 2019

Feb 11, 2020

SELL
$60.18 - $154.77 $2.7 Million - $6.93 Million
-44,800 Reduced 29.67%
106,213 $7.67 Million
Q3 2019

Nov 07, 2019

SELL
$140.29 - $189.96 $1.61 Million - $2.18 Million
-11,500 Reduced 7.08%
151,013 $21.2 Million
Q2 2019

Aug 01, 2019

SELL
$157.85 - $183.09 $489,335 - $567,579
-3,100 Reduced 1.87%
162,513 $29.8 Million
Q1 2019

May 08, 2019

BUY
$89.33 - $163.65 $614,947 - $1.13 Million
6,884 Added 4.34%
165,613 $26.3 Million
Q4 2018

Feb 01, 2019

BUY
$81.94 - $139.71 $300,637 - $512,595
3,669 Added 2.37%
158,729 $15.2 Million
Q3 2018

Nov 01, 2018

BUY
$138.11 - $169.04 $1.87 Million - $2.29 Million
13,566 Added 9.59%
155,060 $21.9 Million
Q2 2018

Jul 31, 2018

BUY
$140.36 - $175.76 $1.35 Million - $1.69 Million
9,611 Added 7.29%
141,494 $22.1 Million
Q1 2018

May 11, 2018

BUY
$152.15 - $192.33 $2.7 Million - $3.41 Million
17,736 Added 15.54%
131,883 $21.2 Million
Q4 2017

Feb 02, 2018

BUY
$60.72 - $167.34 $1.84 Million - $5.06 Million
30,229 Added 36.02%
114,147 $18.8 Million
Q3 2017

Nov 09, 2017

BUY
$61.4 - $88.52 $5.15 Million - $7.43 Million
83,918
83,918 $5.23 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $631M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.